Skip to main content

Advertisement

Log in

Geographic and Racial/Ethnic Variations in Patterns of Multimorbidity Burden in Patients with Type 2 Diabetes

  • Original Research
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

A Capsule Commentary to this article was published on 01 November 2014

ABSTRACT

Background

Multimorbidity presents a significant public health challenge, but regional, rural/urban, and racial/ethnic differences in patterns of multimorbidity in diabetes are poorly understood.

Objective

To describe patterns of multimorbidity in medical and mental health by regional, rural/urban, and racial/ethnic variation in patients with type 2 diabetes mellitus.

Design

Retrospective cohort study from 2002 through 2006

Participants

A national cohort of 892,223 veterans with diabetes

Main Measures

Multimorbidity was the main outcome defined as: the measure of multimorbidity and two categorical outcomes, with pattern of medical and mental health comorbidities combined and separately.

Key Results

Among patients, 52% had 2+ comorbidities, 33% had a single comorbidity, and 14% had no comorbidity; 13.9% had both medical and mental health comorbidities, 70.3% had medical only, and 1.5% had mental health only. The odds of having 3+ comorbidities were nearly fourfold greater in patients 75 years and older relative to patients younger than 50 years (OR=3.95 [95% CI: 3.84, 4.06]). Compared to non-Hispanic whites, the odds of 3+ comorbidities among non-Hispanic blacks were 1.67 times greater (95% CI: 1.63, 1.71). Hispanics were more likely to have a mental health comorbidity alone (OR=1.20 [95% CI: 1.13, 1.28]) than non-Hispanic whites. For patients living in rural areas, the odds were higher of having 3+ comorbidities (OR=1.21 [95% CI: 1.19, 1.23]) and of having both medical and mental health comorbidities (OR=1.15 [95% CI: 1.13, 1.17]) compared to urban dwellers.

Conclusions

Among individuals with diabetes, traditionally disadvantaged groups, including non-Hispanic blacks and rural patients, appear to bear the greatest burden and risk of multimorbidity. Significantly greater odds with increasing number of comorbidities were seen by race/ethnicity, rural residence, and geographic region.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases–a systematic review on existing multimorbidity indices. J Gerontol A, Biol Sci Med Sci. 2011;66(3):301–311.

    Article  Google Scholar 

  2. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–2276.

    Article  PubMed  Google Scholar 

  3. Findley P, Shen C, Sambamoorthi U. Multimorbidity and persistent depression among veterans with diabetes, heart disease, and hypertension. Health Soc Work. 2011;36(2):109–119.

    Article  PubMed  Google Scholar 

  4. Teljeur C, Smith SM, Paul G, Kelly A, O'Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract. 2013;19(1):17–22.

    Article  PubMed  Google Scholar 

  5. Steinman MA, Lee SJ, John Boscardin W, et al. Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc. 2012;60(10):1872–1880.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and Estimates on Diabetes in the United States. Atlanta, GA: U.S. Department of Health and Human Services;2011.

  7. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51(5):367–375.

    Article  PubMed  Google Scholar 

  8. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract: J Royal Coll Gen Pract. 2011;61(582):e12–21.

    Article  Google Scholar 

  9. Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Kadam UT, Croft PR. Clinical multimorbidity and physical function in older adults: a record and health status linkage study in general practice. Fam Pract. 2007;24(5):412–419.

    Article  CAS  PubMed  Google Scholar 

  11. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54(7):661–674.

    Article  CAS  PubMed  Google Scholar 

  12. Payne RA, Abel GA, Guthrie B, Mercer SW. The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study. CMAJ: Can Med Assoc J = Journal de l'Association Medicale Canadienne. 2013;185(5):E221–228.

    Article  Google Scholar 

  13. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.

    Article  PubMed  Google Scholar 

  14. Mathur R, Hull SA, Badrick E, Robson J. Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management. Br J Gen Pract: J Royal Coll Gen Pract. 2011;61(586):e262–270.

    Article  Google Scholar 

  15. Lynch CP, Gebregziabher M, Echols C, Gilbert GE, Zhao Y, Egede LE. Racial disparities in all-cause mortality among veterans with type 2 diabetes. J Gen Intern Med. 2010;25(10):1051–1056.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes. Med Care. 2010;48(6):527–533.

    Article  PubMed  Google Scholar 

  17. Egede LE, Gebregziabher M, Hunt KJ, et al. Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes. Diabetes Care. 2011;34(4):938–943.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Egede LE, Gebregziabher M, Hunt KJ, et al. Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes (February). Ann Pharmacother. 2011;45(2):169–178.

    Google Scholar 

  19. Sinnige J, Braspenning J, Schellevis F, Stirbu-Wagner I, Westert G, Korevaar J. The prevalence of disease clusters in older adults with multiple chronic diseases - a systematic literature review. PLoS One. 2013;8(11):e79641.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(Suppl 2):B10–21.

    Article  PubMed  Google Scholar 

  21. West AN, Lee RE, Shambaugh-Miller MD, et al. Defining “rural” for veterans’ healthcare planning. Journal of Rural Health (in press).

  22. Department of Veterans Affairs Field Research Advisory Committee. (2004). Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Field Research Advisory Committee Operating Procedures. . 2004; http://www.research.va.gov/about/frac/FRAC-ops.pdf.

  23. Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533–2539.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Egede LE, Lynch CP, Gebregziabher M, et al. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2013;28(2):208–215.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal Effects of Medication Nonadherence on Glycemic Control. Ann Pharmacother. Feb 28 2014.

  26. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–151.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.

    Article  PubMed  Google Scholar 

  28. Hilbe JM. Negative Binomial Regression: Cambridge University Press; 2008

  29. Vimalananda VG, Miller DR, Christiansen CL, Wang W, Tremblay P, Fincke BG. Cardiovascular disease risk factors among women veterans at VA medical facilities. J Gen Intern Med. 2013;28(Suppl 2):S517–523.

    Article  PubMed  Google Scholar 

  30. Yoon J, Scott JY, Phibbs CS, Frayne SM. Trends in rates and attributable costs of conditions among female VA patients, 2000 and 2008. Womens Health Issues. 2012;22(3):e337–344.

    Article  PubMed  Google Scholar 

  31. Frayne SM, Parker VA, Christiansen CL, et al. Health status among 28,000 women veterans. The VA Women's health program evaluation project. J Gen Intern Med. 2006;21(Suppl 3):S40–46.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Piette JD, Kerr E, Richardson C, Heisler M. Veterans affairs research on health information technologies for diabetes self-management support. J Diabetes Sci Technol. 2008;2(1):15–23.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Marteau TM, Mann E, Prevost AT, et al. Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial. BMJ. 2010;340:c2138.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Orton E, Forbes-Haley A, Tunbridge L, Cohen S. Equity of uptake of a diabetic retinopathy screening programme in a geographically and socio-economically diverse population. Public Health. 2013;127(9):814–821.

    Article  CAS  PubMed  Google Scholar 

  35. Bowles KH. Nurse practitioner provided home telemonitoring and medication management improves glycemic control in primary care patients with type 2 diabetes more than monthly care coordination telephone call. Evid-Based Nurs. 2010;13(3):74–75.

    Article  PubMed  Google Scholar 

  36. McFarland M, Davis K, Wallace J, et al. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012;32(5):420–426.

    Article  PubMed  Google Scholar 

  37. Stone RA, Rao RH, Sevick MA, et al. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care. 2010;33(3):478–484.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Stone RA, Sevick MA, Rao RH, et al. The diabetes telemonitoring study extension: an exploratory randomized comparison of alternative interventions to maintain glycemic control after withdrawal of diabetes home telemonitoring. J Am Med Inform Assoc: JAMIA. 2012;19(6):973–979.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Cornell JE, Pugh JA, Williams JW, et al. Multimorbidity clusters: clustering binary data from multimorbidity clusters: clustering binary data from a large administrative medical database. Appl Multivar Res. 2007;12(3):163–182.

    Google Scholar 

Download references

ACKNOWLEDGMENT

1. This study was supported by grant #IIR-06-219 funded by the VHA Health Services Research and Development (HSR&D) program. The funding agency did not participate in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The manuscript represents the views of the authors and does not reflect those of the VA or HSR&D.

2. Drs. Leonard E Egede and Mulugeta Gebregziabher are the guarantors of this work, and as such, had full access to all data in the study, and take responsibility for the integrity of the data and the accuracy of the data analysis.

3. This work has not previously been presented.

Conflict of Interest

The authors each declare that they have no conflict of interest.

Authors’ Contributions

Study concept and design: Egede, Gebregziabher, Axon, Hunt, Lynch

Acquisition of data: Egede

Analysis and interpretation of data: Gebregziabher, Hunt, Payne, Egede

Drafting of the manuscript: Egede, Lynch, Gebregziabher, Axon, Hunt, Payne

Critical revision of the manuscript for important intellectual content: Lynch, Gebregziabher, Axon, Hunt, Payne, Egede

Final approval of manuscript: Lynch, Axon, Gebregziabher, Hunt, Egede, Payne

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leonard E. Egede MD, MS.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lynch, C.P., Gebregziabher, M., Axon, R.N. et al. Geographic and Racial/Ethnic Variations in Patterns of Multimorbidity Burden in Patients with Type 2 Diabetes. J GEN INTERN MED 30, 25–32 (2015). https://doi.org/10.1007/s11606-014-2990-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-014-2990-y

Keywords

Navigation